Hui Chuan Yang

Sinopharm Guizhou Blood Products Co., Ltd. engages in the manufacture, sale, research and development of blood plasma-based biopharmaceutical products. Its products include human serum albumin, intravenous immunoglobulin, human immunoglobulin, hepatitis B immunoglobulin and tetanus human immunoglobulin. The company was founded on June 28, 2006 and is headquartered in Kaili, China.

Chengdu Rongsheng Pharmaceutical Co., Ltd. engages in the research and development of biological products. Its business scope includes transfer of scientific research achievements, import and export of goods, technology import and export, and production of blood products, The company was founded on March 12, 1997 and is headquartered in Chengdu. China.

China National Biotec Group Co., Ltd. engages in the research and development, and production of biological products. It offers vaccines, immunoglobulin therapy injections, and biochemical reagents. The company was founded on April 18, 1989 and is headquartered in Beijing, China.

China National Biotec Group Co., Ltd. engages in the research and development, and production of biological products. It offers vaccines, immunoglobulin therapy injections, and biochemical reagents. The company was founded on April 18, 1989 and is headquartered in Beijing, China.

Sinopharm Guizhou Blood Products Co., Ltd. engages in the manufacture, sale, research and development of blood plasma-based biopharmaceutical products. Its products include human serum albumin, intravenous immunoglobulin, human immunoglobulin, hepatitis B immunoglobulin and tetanus human immunoglobulin. The company was founded on June 28, 2006 and is headquartered in Kaili, China.

Chengdu Rongsheng Pharmaceutical Co., Ltd. engages in the research and development of biological products. Its business scope includes transfer of scientific research achievements, import and export of goods, technology import and export, and production of blood products, The company was founded on March 12, 1997 and is headquartered in Chengdu. China.

China National Biotec Group Co., Ltd. engages in the research and development, and production of biological products. It offers vaccines, immunoglobulin therapy injections, and biochemical reagents. The company was founded on April 18, 1989 and is headquartered in Beijing, China.

Sinopharm Guizhou Blood Products Co., Ltd. engages in the manufacture, sale, research and development of blood plasma-based biopharmaceutical products. Its products include human serum albumin, intravenous immunoglobulin, human immunoglobulin, hepatitis B immunoglobulin and tetanus human immunoglobulin. The company was founded on June 28, 2006 and is headquartered in Kaili, China.

Chengdu Rongsheng Pharmaceutical Co., Ltd. engages in the research and development of biological products. Its business scope includes transfer of scientific research achievements, import and export of goods, technology import and export, and production of blood products, The company was founded on March 12, 1997 and is headquartered in Chengdu. China.

Chengdu Rongsheng Pharmaceutical Co., Ltd. engages in the research and development of biological products. Its business scope includes transfer of scientific research achievements, import and export of goods, technology import and export, and production of blood products, The company was founded on March 12, 1997 and is headquartered in Chengdu. China.

China National Biotec Group Co., Ltd. engages in the research and development, and production of biological products. It offers vaccines, immunoglobulin therapy injections, and biochemical reagents. The company was founded on April 18, 1989 and is headquartered in Beijing, China.

Sinopharm Guizhou Blood Products Co., Ltd. engages in the manufacture, sale, research and development of blood plasma-based biopharmaceutical products. Its products include human serum albumin, intravenous immunoglobulin, human immunoglobulin, hepatitis B immunoglobulin and tetanus human immunoglobulin. The company was founded on June 28, 2006 and is headquartered in Kaili, China.

China National Biotec Group Co., Ltd. engages in the research and development, and production of biological products. It offers vaccines, immunoglobulin therapy injections, and biochemical reagents. The company was founded on April 18, 1989 and is headquartered in Beijing, China.

Sinopharm Guizhou Blood Products Co., Ltd. engages in the manufacture, sale, research and development of blood plasma-based biopharmaceutical products. Its products include human serum albumin, intravenous immunoglobulin, human immunoglobulin, hepatitis B immunoglobulin and tetanus human immunoglobulin. The company was founded on June 28, 2006 and is headquartered in Kaili, China.

Sinopharm Guizhou Blood Products Co., Ltd. engages in the manufacture, sale, research and development of blood plasma-based biopharmaceutical products. Its products include human serum albumin, intravenous immunoglobulin, human immunoglobulin, hepatitis B immunoglobulin and tetanus human immunoglobulin. The company was founded on June 28, 2006 and is headquartered in Kaili, China.

China National Biotec Group Co., Ltd. engages in the research and development, and production of biological products. It offers vaccines, immunoglobulin therapy injections, and biochemical reagents. The company was founded on April 18, 1989 and is headquartered in Beijing, China.

China National Biotec Group Co., Ltd. engages in the research and development, and production of biological products. It offers vaccines, immunoglobulin therapy injections, and biochemical reagents. The company was founded on April 18, 1989 and is headquartered in Beijing, China.

Sinopharm Guizhou Blood Products Co., Ltd. engages in the manufacture, sale, research and development of blood plasma-based biopharmaceutical products. Its products include human serum albumin, intravenous immunoglobulin, human immunoglobulin, hepatitis B immunoglobulin and tetanus human immunoglobulin. The company was founded on June 28, 2006 and is headquartered in Kaili, China.

Chengdu Rongsheng Pharmaceutical Co., Ltd. engages in the research and development of biological products. Its business scope includes transfer of scientific research achievements, import and export of goods, technology import and export, and production of blood products, The company was founded on March 12, 1997 and is headquartered in Chengdu. China.

China National Biotec Group Co., Ltd. engages in the research and development, and production of biological products. It offers vaccines, immunoglobulin therapy injections, and biochemical reagents. The company was founded on April 18, 1989 and is headquartered in Beijing, China.